Fundamentals - Income Statement

  Year Ending Dec 2025 (Update) Year Ending Dec 2024 (Update) Year Ending Dec 2023 (Update) Year Ending Dec 2022 (Update) Year Ending Dec 2021 (Update)
Net Sales 1,422.53 1,154.60 1,058.65 951.12 864.50
Revenue 1,422.53 1,154.60 1,058.65 951.12 864.50
Total Revenue 1,422.53 1,154.60 1,058.65 951.12 864.50
Cost of Revenue 960.66 779.58 717.08 642.38 594.65
Cost of Revenue, Total 960.66 779.58 717.08 642.38 594.65
Gross Profit 461.87 375.02 341.58 308.74 269.85
Selling/General/Administrative Expense 306.85 253.83 234.79 216.94 182.11
Selling/General/Administrative Expenses, Total 306.85 253.83 234.79 216.94 182.11
Depreciation 16.41 13.53 14.13 14.06 14.49
Depreciation/Amortization 16.41 13.53 14.13 14.06 14.49
Impairment-Assets Held for Use 0.00 4.97 -- -- --
Loss (Gain) on Sale of Assets - Operating -- -- -- -- --
Other Unusual Expense (Income) -- -- 1.70 9.00 7.31
Unusual Expense (Income) 0.00 4.97 1.70 9.00 7.31
Total Operating Expense 1,283.92 1,051.91 967.70 882.38 798.56
Operating Income 138.62 102.69 90.96 68.74 65.94
Interest Expense - Non-Operating -13.61 -7.73 -11.11 -8.91 -5.81
Interest Expense, Net Non-Operating -13.61 -7.73 -11.11 -8.91 -5.81
Interest Income, Non-Operating 2.44 4.39 1.48 0.34 0.27
Interest/Investment Income, Non-Operating 2.44 4.39 1.48 0.34 0.27
Interest Income (Expense), Net-Non-Operating, Total -11.17 -3.34 -9.63 -8.57 -5.54
Other Non-Operating Income (Expense) -- -- -- -- --
Other, Net -- -- -- -- --
Net Income Before Taxes 127.45 99.35 81.33 60.17 60.40
Income Tax – Total 31.54 25.76 18.81 14.15 15.27
Income After Tax 95.91 73.60 62.52 46.03 45.13
Net Income Before Extraordinary Items 95.91 73.60 62.52 46.03 45.13
Discontinued Operations -- -- -- -- --
Extraordinary Item -- -- -- -- 0.00
Tax on Extraordinary Items -- -- -- -- --
Total Extraordinary Items -- -- -- -- 0.00
Net Income 95.91 73.60 62.52 46.03 45.13
Income Available to Common Excluding Extraordinary Items 95.91 73.60 62.52 46.03 45.13
Income Available to Common Stocks Including Extraordinary Items 95.91 73.60 62.52 46.03 45.13
Basic Weighted Average Shares 18.05 17.01 16.00 15.86 15.74
Basic EPS Excluding Extraordinary Items 5.31 4.33 3.91 2.90 2.87
Basic EPS Including Extraordinary Items 5.31 4.33 3.91 2.90 2.87
Diluted Net Income 95.91 73.60 62.52 46.03 45.13
Diluted Weighted Average Shares 18.39 17.38 16.31 16.18 16.06
Diluted EPS Excluding Extraordinary Items 5.22 4.23 3.83 2.84 2.81
Diluted EPS Including Extraordinary Items 5.22 4.23 3.83 2.84 2.81
Gross Dividends - Common Stock 0.00 0.00 0.00 0.00 0.00
(Gain) Loss on Sale of Assets, Supplemental 0.00 -3.74 0.00 -0.06 0.03
Restructuring Charge, Supplemental 1.50 0.00 0.27 0.46 1.06
Other Unusual Expense (Income), Supplemental 8.90 14.68 6.22 7.66 --
Non-Recurring Items, Total 10.40 10.94 6.49 8.06 1.08
Total Special Items 10.40 15.91 8.19 17.06 8.39
Normalized Income Before Taxes 137.84 115.26 89.51 77.23 68.79
Effect of Special Items on Income Taxes 2.57 4.12 1.89 4.01 2.12
Income Taxes Excluding Impact of Special Items 34.11 29.88 20.70 18.16 17.39
Normalized Income After Taxes 103.73 85.38 68.81 59.07 51.39
Normalized Income Available to Common 103.73 85.38 68.81 59.07 51.39
Basic Normalized EPS 5.75 5.02 4.30 3.72 3.27
Diluted Normalized EPS 5.64 4.91 4.22 3.65 3.20
Amortization of Intangibles, Supplemental 8.40 6.70 7.10 7.20 8.50
Depreciation, Supplemental 8.01 6.83 7.03 6.86 5.99
Interest Expense, Supplemental 13.61 7.73 11.11 8.91 5.81
Rental Expense, Supplemental 14.66 13.39 13.03 11.35 11.15
Stock-Based Compensation, Supplemental 16.42 11.17 10.32 10.63 9.43
Audit-Related Fees, Supplemental -- 2.52 2.44 2.14 1.75
Audit-Related Fees -- 1.47 0.02 0.12 0.00
Tax Fees, Supplemental -- 0.31 0.04 0.08 0.03
All Other Fees Paid to Auditor, Supplemental -- 0.00 0.00 0.00 --
Gross Margin 32.47 32.48 32.27 32.46 31.21
Operating Margin 9.74 8.89 8.59 7.23 7.63
Pretax Margin 8.96 8.60 7.68 6.33 6.99
Effective Tax Rate 24.74 25.92 23.13 23.51 25.29
Net Profit Margin 6.74 6.37 5.91 4.84 5.22
Normalized EBIT 149.01 118.60 99.14 85.80 74.32
Normalized EBITDA 165.42 132.13 113.27 99.86 88.82
Current Tax - Domestic 10.78 9.00 11.84 7.08 4.60
Current Tax - Local 2.89 3.53 4.14 3.09 2.40
Current Tax - Total 13.67 12.53 15.98 10.17 7.00
Deferred Tax - Domestic 14.73 11.26 2.31 3.12 6.41
Deferred Tax - Local 3.14 1.97 0.53 0.86 1.86
Deferred Tax - Total 17.87 13.22 2.83 3.98 8.27
Income Tax - Total 31.54 25.76 18.81 14.15 15.27
Defined Contribution Expense - Domestic 0.70 0.80 0.60 0.40 0.40
Total Pension Expense 0.70 0.80 0.60 0.40 0.40
Patient Days 1,369,425.00 1,266,701.00 1,203,522.00 1,176,193.00 923,014.00

In millions of USD (except for per share items)

For a more complete picture of our financial results, please review our SEC Filings

Source: LSEG